15th DIA Japan Annual Meeting 2018

Innovative technologies such as AI, big data/genomics, and cell/gene therapies are poised to transform healthcare product development across the globe – join us to discuss these topics.

返回 Agenda

[V8-S1] Target Product Profile - Better Way to Build Up R&D Management Plan [Call for Abstract Session]

Session Chair(s)

Yoshio Marumoto, MD, PhD

Associate Professor

Yamaguchi University Hospital, Japan

In this session, general TPP configuration items will be outlined with reference to FDA guidance. Furthermore, from the viewpoint of program management and scope management in the R & D process, we examine how effective TPP should be.

Speaker(s)

Project Management Checklist in AMED

Michiko Ishida, DrSc

Japan Agency for Medical Research and Development (AMED), Japan

Director, Department of Innovative Drug Discovery and Development

Use of the TPP as a Tool in Academia

Shinobu Shimizu, PhD

Nagoya Univeresity Hospital, Japan

Associate Professor, Department of Advanced Medicine

General Concept for TPP Utilization in Pharmaceutical Company

Atsushi Tsukamoto, PhD, MSc

Daiichi Sankyo, United States

Corporate Officer, Head is Therapeutic Area Strategies